Growth,regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate |
| |
Authors: | W. Bursch B. Düsterberg R. Schulte-Hermann |
| |
Affiliation: | (1) Institut für Toxikologie und Pharmakologie der Universität Marburg, Pilgrimstein 2, D-3550 Marburg, Federal Republic of Germany;(2) Department of Pharmacokinetics, Schering AG, Müllerstr. 170-178, D-1000 Berlin 65, Federal Republic of Germany;(3) Present address: Institut für Tumorbiologie-Krebsforschung, Borschkegasse 8a, A-1090 Vienna, Austria |
| |
Abstract: | Previous studies have shown that xenobiotic compounds such as the environmental pollutant -hexa-chlorocyclohexane (-HCH) and the synthetic sex steroid cyproterone acetate (CPA) induce growth of rat liver by hypertrophy and hyperplasia. After withdrawal of the growth stimuli, liver hypertrophy was usually found to be readily reversible. Conflicting observations were made concerning the fate of liver hyperplasia: hepatic hyperplasia persisted when induced by -HCH but was found to be partially reversible when induced by CPA. The present study confirms the reversibility of hepatic hyperplasia induced by CPA in rats: about 30% of liver DNA present at maximal liver enlargement disappeared within 6 days after cessation of CPA treatment. Simultaneously, a dramatic increase in the rate of cell elimination by apoptosis was found. Glutamate-pyruvate transaminase and alkaline phosphatase in serum did not show major increases, suggesting that cell death was not due to lytic membrane damage. Furthermore, if treatment with CPA was continued or resumed, the enhanced DNA content persisted and the number of apoptotic bodies was greatly reduced. These observations suggest that the occurrence of cell death is due to withdrawal of the growth stimulus CPA. It may reflect a regulatory phenomenon serving to maintain homeostasis of cell number.Further studies showed that CPA is rapidly eliminated from rat liver and serum: t 1/2 in the liver is about 11 h. In contrast, -HCH was previously found to be eliminated more slowly: t 1/2 approximately 144 h. The present study revealed that -HCH, CPA and nafenopin lower the number of apoptotic bodies. This suggests that inducers of liver growth can inhibit hepatocellular death by apoptosis. It is concluded that the regression of hyperplasia after CPA withdrawal may be due to its rapid elimination. On the other hand the relatively long persistence of -HCH may result in inhibition of cell death and thereby stabilize hepatic hyperplasia.Abbreviations CPA cyproterone acetate - -HCH -hexachlorocyclohexane - PB phenobarbital - NAF nafenopin - AB apoptotic body - b.w. body weight - p. admin. post-administration - GPT glutamate-pyruvate transaminase - ALP alkaline phosphataseDedicated to Professor W. Koransky on the occasion of his 65th birthday |
| |
Keywords: | Apoptosis Cell death Liver hyperplasia regression Cyproterone acetate /content/p53485535258823x/xxlarge945.gif" alt=" agr" align=" BASELINE" BORDER=" 0" >-Hexachlorocyclohexane nafenopin Pharmacokinetics Serum glutamate pyruvate transaminase Serum alkaline phosphatase |
本文献已被 SpringerLink 等数据库收录! |
|